Cambridge, Ontario (August 7, 2014): now available from Bimeda-MTC: LincoMed 100™ (lincomycin 100 mg/mL), an antibiotic for use in swine supplied in 100 mL multiple-dose vials as a sterile solution. DIN 0242142, Approved by Health Canada. Manufactured by Bimeda-MTC, Cambridge, ON, Canada.
Lincomed™ is indicated for the treatment of infectious forms of arthritis caused by organisms sensitive to its activity. This includes most of the organisms responsible for the various infectious arthritides in swine, such as Staphylococci, Streptococci, Erysipelothrix and Mycoplasma spp.
It is also indicated for the treatment of swine dysentery.
This product will be available through Bimeda-MTC’s authorized animal health veterinary product distributors. For more information regarding availability call 1-519-654-8048.
For complete product labeling and more information visit www.bimedamtc.com
Federal law restricts this drug to use by or on the order of a licensed veterinarian.
For use only in swine.
It is not recommended that LincoMed™100 be used to treat or control outbreaks of swine dysentery. The use of LincoMed™100 in extremely sick or moribund pigs suffering from swine dysentery is recommended until appetite and/or water consumption improvements allow adequate intake of oral medication.
Bimeda is a global manufacturer and marketer of a variety of unique and generic animal health pharmaceutical product dosage forms produced in seven manufacturing plants in Brazil, Canada, Ireland, Kenya, U.K and the USA. Additional information regarding Bimeda and their products is available by visiting www.bimeda.com or calling 1-888-524-6332.
Bimeda’s US headquarters is located in Oakbrook Terrace, IL.
Bimeda-MTC is located in Cambridge, ON 519-654-8048